Motto International Corp recalls Bull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text, packaged in 2, 4 and 10
Motto International recalls Bull Platinum 30000 Capsules (1000mg) due to FDA finding tadalfil without approved NDA/ANDA. All remaining lots within expiry date.
Recall notice
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Contact the company & request your remedy
What happened, in plain English
Motto International is recalling Bull Platinum 30000 Capsules (1000mg) because the FDA found the product contains tadalfil without proper regulatory approval. This could pose a risk to consumers using the product without the required safety reviews. Read more at govinfonow.com/recall/37640-motto-international-bull-platinum-30000-capsules-recall-fda-finds-tadalfil.
Source Summary by GovInfoNow · govinfonow.com/recall/37640-motto-international-bull-platinum-30000-capsules-recall-fda-finds-tadalfil · Updated October 5, 2026 · FDA enforcement record: FDA #D-0654-2020
Cite this page
“Motto International Bull Platinum 30000 Capsules Recall: FDA Finds Tadalfil Without Approval.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37640-motto-international-bull-platinum-30000-capsules-recall-fda-finds-tadalfil. Based on FDA recall #D-0654-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0654-2020%22&limit=1).
Why it’s dangerous
The product was marketed without an FDA-approved drug application (NDA/ANDA) and contains tadalfil, a medication that requires regulatory approval. This means the product may not be safe for use as it lacks proper safety testing and oversight.
Who’s affected
People who own or use Bull Platinum 30000 Capsules (1000mg) from Motto International. Those most at risk are individuals taking the product without knowing it contains an unapproved medication.
How to tell if you have this one
Look for Bull Platinum 30000 Capsules in orange, white, yellow background with silver text, packaged in 2, 4, or 10 count blister cards. All remaining lots are within their expiry date.
- Brand
Motto International- Category
Drug
All 4 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class I- Status
Terminated- Distribution
TX
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0654-2020 | Bull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text, packaged in 2, 4 and 10 count blister cards, Motto International, Dallas, TX; All lots remaining within expiry. | 8 boxes |
| D-0655-2020 | Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX; All lots remaining within expiry. | 7 boxes |
| D-0656-2020 | Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX; All lots remaining within expiry. | 5 boxes |
| D-0657-2020 | Panther Platinum 30000 Capsules, in green, black background with white, red text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX; All lots remaining within expiry. | 1 box |
What to do — step by step
Check Product Details
Verify if your capsules match the description: orange, white, yellow background with silver text, packaged in 2, 4, or 10 count blister cards.
Questions people ask
Is this product safe to use?
The FDA found the product contains tadalfil without approved regulatory status, so it is not safe for use as it lacks required safety reviews.
What should I do if I have this product?
The recall record does not specify a remedy, so no action is required beyond checking if you have the product.
Are there any risks to health?
The product was marketed without an FDA-approved drug application, which could pose health risks due to lack of safety testing.
Contact Motto International
We’ve drafted a message you can send Motto International to request your refund or repair — edit it as you like.
Subject: Recall D-0654-2020 — Motto International Motto International Hello, I own a Motto International that is covered by recall D-0654-2020 from Motto International. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0654-2020 (December 17, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0654-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.